Outcomes of patients (pts) with de novo metastatic hormone-sensitive prostate cancer (mHSPC) who progressed to metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TRUMPET registry.
Meeting Abstract
Shevrin, Daniel H.; Symanowski, James Thomas; Shore, Neal D.; Lin, Daniel W.; Russell, David; Kral, Pavol; Song, Yi; El-Chaar, Nader N.; Karsh, Lawrence Ivan